6533b81ffe1ef96bd1277da5
RESEARCH PRODUCT
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.
Csaba FarsangAntonio CocaXin-hua ZhangGiuseppe ManciaArman PostadzhiyanKrzysztof NarkiewiczStéphane LaurentNieves Martell-clarosFernando PintoYuriy SirenkoJohn T. O'brienRenata CifkovaBojan JelakovićGuido GrassiIrina LazarevaMaria DorobantuZhaosu WuRok AccettoVincenzo SilaniChengbin XuGiovanni CorraoEivind BergePhilippos StylianouDror DickerGianfranco ParatiYuqing ZhangDragan LovicLorenza ScottiGary A. FordRoland E. SchmiederMichel BurnierLisheng LiuMarco Stramba-badialeMargus ViigimaaAnna F. DominiczakTing Rui GuanJose L. RodicioAlexandra KonradiHengge XieAthanasios J. ManolisEnrico Agabiti-roseiRedon JosepPeter M. NilssonGangzhi WeiXuezhong ZhangDingliang ZhuAlberto ZanchettiMaciej BanachGrzegorz BiloAntonella ZambonLuis M. Ruilopesubject
medicine.medical_specialtyPhysiologybusiness.industry030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineBlood pressureSprintShot (pellet)Internal MedicinePhysical therapyMedicine030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessStrokeyear | journal | country | edition | language |
---|---|---|---|---|
2016-01-19 | Journal of hypertension |